Remote patient monitoring is likely to become as essential to healthcare as mobile phones are to modern life. Glooko Chief Commercial Officer Zach Henderson discusses how medical practices can leverage the digital health solution to improve patient care, engagement and satisfaction while generating sizable and consistent revenues.

Glooko Chief Commercial Officer Zach Henderson shares the clinical and financial benefits of healthcare providers, health systems and payers leveraging remote patient monitoring technology to treat patients with chronic conditions.

The expansion of Academy™, a free educational programme from Glooko and the Diabetes Technology Network/Association of British Clinical Diabetologists, into Ireland will help clinicians further increase their knowledge and stay current on new diabetes technologies used to treat patients with the chronic condition.

Glooko announced, in partnership with the Diabetes Technology Network/Association of British Clinical Diabetologists, the expansion into Ireland of Academy™, an online programme focused on diabetes technology and education.

Device-integrating digital health platforms, like Glooko, help bridge diabetes care gaps and enable patients to better manage their condition.

Medidata announced ten highly innovative organizations, including Glooko, have joined its groundbreaking Sensor Cloud Network. The company is making it easier for life science organizations to execute global clinical trials through its Connected Research platform.

Glooko Chief Medical Officer Mark Clements, M.D., Ph.D. discussed the impact of diabetes on public health in the U.S. and how digital health platforms can be leveraged to help better manage chronic conditions.

Glooko’s remote patient monitoring solution allows healthcare providers at Atrius Health to view vast quantities of patient data and monitor a patient’s complete health on one central highly secure platform.

Glooko CEO Russ Johannesson brings Founder and Publisher Matthew Holt up to speed on how the connected care company has expanded globally, made strategic acquisitions and added support for digital therapeutics and decentralized clinical trials.

At ATTD 2022, Glooko CEO Russ Johannessen shares insights with Executive Editor Tina Tan about how AI and other technologies can enable better and more precise management of one of the most prevalent chronic conditions.